Literature DB >> 25092153

Anaemia: FIND-CKD: intravenous iron in predialysis CKD.

Steven Fishbane1, Azzour D Hazzan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25092153     DOI： 10.1038/nrneph.2014.139

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  9 in total

1.  Impairment of transendothelial leukocyte migration by iron complexes.

Authors:  Gürkan Sengoelge; Josef Kletzmayr; Ilse Ferrara; Agnes Perschl; Walter H Hörl; Gere Sunder-Plassmann
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

2.  The new FDA labeling for ESA--implications for patients and providers.

Authors:  Braden J Manns; Marcello Tonelli
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 8.237

3.  Intravenous iron sucrose for restless legs syndrome in pregnant women with low serum ferritin.

Authors:  David Vadasz; Vincent Ries; Wolfgang H Oertel
Journal:  Sleep Med       Date:  2013-09-04       Impact factor: 3.492

4.  Correction of anemia with epoetin alfa in chronic kidney disease.

Authors:  Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

5.  Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.

Authors:  Steven Fishbane; Simcha Pollack; Harold I Feldman; Marshall M Joffe
Journal:  Clin J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 8.237

6.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245

7.  Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease.

Authors:  Rajiv Agarwal; Nina Vasavada; Nadine G Sachs; Shawn Chase
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

8.  Bone marrow iron, iron indices, and the response to intravenous iron in patients with non-dialysis-dependent CKD.

Authors:  Simona Stancu; Ana Stanciu; Adrian Zugravu; Liliana Bârsan; Daniela Dumitru; Mariana Lipan; Gabriel Mircescu
Journal:  Am J Kidney Dis       Date:  2010-01-15       Impact factor: 8.860

9.  FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia.

Authors:  Iain C Macdougall; Andreas H Bock; Fernando Carrera; Kai-Uwe Eckardt; Carlo Gaillard; David Van Wyck; Bernard Roubert; Jacqueline G Nolen; Simon D Roger
Journal:  Nephrol Dial Transplant       Date:  2014-06-02       Impact factor: 5.992
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.